TY - JOUR AU - Angus, D. C. AU - Linde-Zwirble, W. T. AU - Lidicker, J. AU - Clermont, G. AU - Carcillo, J. AU - Pinsky, M. R. PY - 2001 DA - 2001// TI - Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care JO - Crit Care Med VL - 29 UR - https://doi.org/10.1097/00003246-200107000-00002 DO - 10.1097/00003246-200107000-00002 ID - Angus2001 ER - TY - JOUR AU - Gaieski, D. F. AU - Edwards, J. M. AU - Kallan, M. J. AU - Carr, B. G. PY - 2013 DA - 2013// TI - Benchmarking the incidence and mortality of severe sepsis in the United States JO - Crit Care Med VL - 41 UR - https://doi.org/10.1097/CCM.0b013e31827c09f8 DO - 10.1097/CCM.0b013e31827c09f8 ID - Gaieski2013 ER - TY - JOUR AU - Riedemann, N. C. AU - Guo, R. F. AU - Ward, P. A. PY - 2003 DA - 2003// TI - Novel strategies for the treatment of sepsis JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm0503-517 DO - 10.1038/nm0503-517 ID - Riedemann2003 ER - TY - JOUR AU - Vincent, J. L. AU - Opal, S. M. AU - Marshall, J. C. AU - Tracey, K. J. PY - 2013 DA - 2013// TI - Sepsis definitions: time for change JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61815-7 DO - 10.1016/S0140-6736(12)61815-7 ID - Vincent2013 ER - TY - JOUR AU - Gogos, C. A. AU - Drosou, E. AU - Bassaris, H. P. AU - Skoutelis, A. PY - 2000 DA - 2000// TI - Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options JO - J Infect Dis VL - 181 UR - https://doi.org/10.1086/315214 DO - 10.1086/315214 ID - Gogos2000 ER - TY - JOUR AU - Reinhart, K. AU - Karzai, W. PY - 2001 DA - 2001// TI - Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned JO - Crit Care Med VL - 29 UR - https://doi.org/10.1097/00003246-200107001-00037 DO - 10.1097/00003246-200107001-00037 ID - Reinhart2001 ER - TY - JOUR AU - Cohen, J. PY - 2002 DA - 2002// TI - The immunopathogenesis of sepsis JO - Nature VL - 420 UR - https://doi.org/10.1038/nature01326 DO - 10.1038/nature01326 ID - Cohen2002 ER - TY - JOUR AU - Yoshimura, A. AU - Naka, T. AU - Kubo, M. PY - 2007 DA - 2007// TI - SOCS proteins, cytokine signalling and immune regulation JO - Nat Rev Immunol VL - 7 UR - https://doi.org/10.1038/nri2093 DO - 10.1038/nri2093 ID - Yoshimura2007 ER - TY - JOUR AU - Fang, M. AU - Dai, H. AU - Yu, G. AU - Gong, F. PY - 2005 DA - 2005// TI - Gene delivery of SOCS3 protects mice from lethal endotoxic shock JO - Cell Mol Immunol VL - 2 ID - Fang2005 ER - TY - JOUR AU - Nair, S. AU - Pandey, A. D. AU - Mukhopadhyay, S. PY - 2011 DA - 2011// TI - The PPE18 protein of Mycobacterium tuberculosis inhibits NF-kappaB/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein JO - J Immunol VL - 186 UR - https://doi.org/10.4049/jimmunol.1000773 DO - 10.4049/jimmunol.1000773 ID - Nair2011 ER - TY - JOUR AU - Narayana, Y. AU - Bansal, K. AU - Sinha, A. Y. AU - Kapoor, N. AU - Puzo, G. AU - Gilleron, M. PY - 2009 DA - 2009// TI - SOCS3 expression induced by PIM2 requires PKC and PI3K signaling JO - Mol Immunol VL - 46 UR - https://doi.org/10.1016/j.molimm.2009.06.019 DO - 10.1016/j.molimm.2009.06.019 ID - Narayana2009 ER - TY - JOUR AU - Qin, H. AU - Roberts, K. L. AU - Niyongere, S. A. AU - Cong, Y. AU - Elson, C. O. AU - Benveniste, E. N. PY - 2007 DA - 2007// TI - Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.9.5966 DO - 10.4049/jimmunol.179.9.5966 ID - Qin2007 ER - TY - JOUR AU - Qin, H. AU - Holdbrooks, A. T. AU - Liu, Y. AU - Reynolds, S. L. AU - Yanagisawa, L. L. AU - Benveniste, E. N. PY - 2012 DA - 2012// TI - SOCS3 deficiency promotes M1 macrophage polarization and inflammation JO - J Immunol VL - 189 UR - https://doi.org/10.4049/jimmunol.1201168 DO - 10.4049/jimmunol.1201168 ID - Qin2012 ER - TY - JOUR AU - Zhou, G. X. AU - Chao, L. AU - Chao, J. PY - 1992 DA - 1992// TI - Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence JO - J Biol Chem VL - 267 UR - https://doi.org/10.1016/S0021-9258(18)35690-4 DO - 10.1016/S0021-9258(18)35690-4 ID - Zhou1992 ER - TY - JOUR AU - Chao, J. AU - Chao, L. PY - 1995 DA - 1995// TI - Biochemistry, regulation and potential function of kallistatin JO - Biol Chem Hoppe Seyler VL - 376 ID - Chao1995 ER - TY - JOUR AU - Miao, R. Q. AU - Agata, J. AU - Chao, L. AU - Chao, J. PY - 2002 DA - 2002// TI - Kallistatin is a new inhibitor of angiogenesis and tumor growth JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-01-0185 DO - 10.1182/blood-2002-01-0185 ID - Miao2002 ER - TY - JOUR AU - Miao, R. Q. AU - Chen, V. AU - Chao, L. AU - Chao, J. PY - 2003 DA - 2003// TI - Structural elements of kallistatin required for inhibition of angiogenesis JO - Am J Physiol Cell Physiol VL - 284 UR - https://doi.org/10.1152/ajpcell.00524.2002 DO - 10.1152/ajpcell.00524.2002 ID - Miao2003 ER - TY - JOUR AU - Wang, C. R. AU - Chen, S. Y. AU - Wu, C. L. AU - Liu, M. F. AU - Jin, Y. T. AU - Chao, L. PY - 2005 DA - 2005// TI - Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.20991 DO - 10.1002/art.20991 ID - Wang2005 ER - TY - JOUR AU - Shen, B. AU - Hagiwara, M. AU - Yao, Y. Y. AU - Chao, L. AU - Chao, J. PY - 2008 DA - 2008// TI - Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress JO - Hypertension VL - 51 UR - https://doi.org/10.1161/HYPERTENSIONAHA.107.108514 DO - 10.1161/HYPERTENSIONAHA.107.108514 ID - Shen2008 ER - TY - JOUR AU - Shen, B. AU - Gao, L. AU - Hsu, Y. T. AU - Bledsoe, G. AU - Hagiwara, M. AU - Chao, L. PY - 2010 DA - 2010// TI - Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling JO - Am J Physiol Heart Circ Physiol VL - 299 UR - https://doi.org/10.1152/ajpheart.00591.2010 DO - 10.1152/ajpheart.00591.2010 ID - Shen2010 ER - TY - JOUR AU - Yin, H. AU - Gao, L. AU - Shen, B. AU - Chao, L. AU - Chao, J. PY - 2010 DA - 2010// TI - Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation JO - Hypertension VL - 56 UR - https://doi.org/10.1161/HYPERTENSIONAHA.110.152330 DO - 10.1161/HYPERTENSIONAHA.110.152330 ID - Yin2010 ER - TY - JOUR AU - Chao, J. AU - Schmaier, A. AU - Chen, L. M. AU - Yang, Z. AU - Chao, L. PY - 1996 DA - 1996// TI - Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease JO - J Lab Clin Med VL - 127 UR - https://doi.org/10.1016/S0022-2143(96)90152-3 DO - 10.1016/S0022-2143(96)90152-3 ID - Chao1996 ER - TY - JOUR AU - Chen, L. M. AU - Chao, L. AU - Chao, J. PY - 1997 DA - 1997// TI - Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock JO - Life Sci VL - 60 UR - https://doi.org/10.1016/S0024-3205(97)00094-5 DO - 10.1016/S0024-3205(97)00094-5 ID - Chen1997 ER - TY - JOUR AU - Lu, S. L. AU - Tsai, C. Y. AU - Luo, Y. H. AU - Kuo, C. F. AU - Lin, W. C. AU - Chang, Y. T. PY - 2013 DA - 2013// TI - Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from group A streptococcal infection JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00322-13 DO - 10.1128/AAC.00322-13 ID - Lu2013 ER - TY - JOUR AU - Li, P. AU - Bledsoe, G. AU - Yang, Z. R. AU - Fan, H. AU - Chao, L. AU - Chao, J. PY - 2014 DA - 2014// TI - Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis JO - Immunology VL - 142 UR - https://doi.org/10.1111/imm.12242 DO - 10.1111/imm.12242 ID - Li2014 ER - TY - JOUR AU - Chen, V. C. AU - Chao, L. AU - Chao, J. PY - 2000 DA - 2000// TI - Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis JO - Biochim Biophys Acta VL - 1479 UR - https://doi.org/10.1016/S0167-4838(00)00044-3 DO - 10.1016/S0167-4838(00)00044-3 ID - Chen2000 ER - TY - JOUR AU - Ohkawa, H. AU - Ohishi, N. AU - Yagi, K. PY - 1979 DA - 1979// TI - Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction JO - Anal Biochem VL - 95 UR - https://doi.org/10.1016/0003-2697(79)90738-3 DO - 10.1016/0003-2697(79)90738-3 ID - Ohkawa1979 ER - TY - JOUR AU - Chen, V. C. AU - Chao, L. AU - Chao, J. PY - 2000 DA - 2000// TI - A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M005691200 DO - 10.1074/jbc.M005691200 ID - Chen2000 ER - TY - JOUR AU - Chen, V. C. AU - Chao, L. AU - Pimenta, D. C. AU - Bledsoe, G. AU - Juliano, L. AU - Chao, J. PY - 2001 DA - 2001// TI - Identification of a major heparin-binding site in kallistatin JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M005791200 DO - 10.1074/jbc.M005791200 ID - Chen2001 ER - TY - JOUR AU - Duan, G. AU - Zhu, J. AU - Xu, J. AU - Liu, Y. PY - 2014 DA - 2014// TI - Targeting myeloid differentiation 2 for treatment of sepsis JO - Front Biosci (Landmark Ed) VL - 19 UR - https://doi.org/10.2741/4256 DO - 10.2741/4256 ID - Duan2014 ER - TY - JOUR AU - Ebong, S. AU - Call, D. AU - Nemzek, J. AU - Bolgos, G. AU - Newcomb, D. AU - Remick, D. PY - 1999 DA - 1999// TI - Immunopathologic alterations in murine models of sepsis of increasing severity JO - Infect Immun VL - 67 UR - https://doi.org/10.1128/IAI.67.12.6603-6610.1999 DO - 10.1128/IAI.67.12.6603-6610.1999 ID - Ebong1999 ER - TY - JOUR AU - Riedemann, N. C. AU - Neff, T. A. AU - Guo, R. F. AU - Bernacki, K. D. AU - Laudes, I. J. AU - Sarma, J. V. PY - 2003 DA - 2003// TI - Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression JO - J Immunol VL - 170 UR - https://doi.org/10.4049/jimmunol.170.1.503 DO - 10.4049/jimmunol.170.1.503 ID - Riedemann2003 ER - TY - JOUR AU - Yang, H. AU - Ochani, M. AU - Li, J. AU - Qiang, X. AU - Tanovic, M. AU - Harris, H. E. PY - 2004 DA - 2004// TI - Reversing established sepsis with antagonists of endogenous high-mobility group box 1 JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.2434651100 DO - 10.1073/pnas.2434651100 ID - Yang2004 ER - TY - JOUR AU - Naka, T. AU - Fujimoto, M. AU - Tsutsui, H. AU - Yoshimura, A. PY - 2005 DA - 2005// TI - Negative regulation of cytokine and TLR signalings by SOCS and others JO - Adv Immunol VL - 87 UR - https://doi.org/10.1016/S0065-2776(05)87003-8 DO - 10.1016/S0065-2776(05)87003-8 ID - Naka2005 ER - TY - JOUR AU - Dai, Z. AU - Lu, L. AU - Yang, Z. AU - Mao, Y. AU - Lu, J. AU - Li, C. PY - 2013 DA - 2013// TI - Kallikrein-binding protein inhibits LPS-induced TNF-alpha by upregulating SOCS3 expression JO - J Cell Biochem VL - 114 UR - https://doi.org/10.1002/jcb.24441 DO - 10.1002/jcb.24441 ID - Dai2013 ER - TY - JOUR AU - Shen, B. AU - Smith, R. S. AU - Hsu, Y. T. AU - Chao, L. AU - Chao, J. PY - 2009 DA - 2009// TI - Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M109.046813 DO - 10.1074/jbc.M109.046813 ID - Shen2009 ER - TY - JOUR AU - Roger, T. AU - Froidevaux, C. AU - Roy, D. AU - Reymond, M. K. AU - Chanson, A. L. AU - Mauri, D. PY - 2009 DA - 2009// TI - Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4 JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0808146106 DO - 10.1073/pnas.0808146106 ID - Roger2009 ER - TY - JOUR AU - Kim, T. H. AU - Yoon, S. J. AU - Lee, S. M. PY - 2012 DA - 2012// TI - Genipin attenuates sepsis by inhibiting Toll-like receptor signaling JO - Mol Med VL - 18 UR - https://doi.org/10.2119/molmed.2011.00308 DO - 10.2119/molmed.2011.00308 ID - Kim2012 ER - TY - JOUR AU - Yang, H. AU - Tracey, K. J. PY - 2010 DA - 2010// TI - Targeting HMGB1 in inflammation JO - Biochim Biophys Acta VL - 1799 UR - https://doi.org/10.1016/j.bbagrm.2009.11.019 DO - 10.1016/j.bbagrm.2009.11.019 ID - Yang2010 ER - TY - JOUR AU - Montmollin, E. AU - Annane, D. PY - 2011 DA - 2011// TI - Year in review 2010: Critical care–multiple organ dysfunction and sepsis JO - Crit Care VL - 15 UR - https://doi.org/10.1186/cc10359 DO - 10.1186/cc10359 ID - Montmollin2011 ER - TY - JOUR AU - Frank, A. J. AU - Sheu, C. C. AU - Zhao, Y. AU - Chen, F. AU - Su, L. AU - Gong, M. N. PY - 2012 DA - 2012// TI - BCL2 genetic variants are associated with acute kidney injury in septic shock* JO - Crit Care Med VL - 40 UR - https://doi.org/10.1097/CCM.0b013e3182514bca DO - 10.1097/CCM.0b013e3182514bca ID - Frank2012 ER - TY - JOUR AU - Reuter, S. AU - Gupta, S. C. AU - Chaturvedi, M. M. AU - Aggarwal, B. B. PY - 2010 DA - 2010// TI - Oxidative stress, inflammation, and cancer: how are they linked? JO - Free Radic Biol Med VL - 49 UR - https://doi.org/10.1016/j.freeradbiomed.2010.09.006 DO - 10.1016/j.freeradbiomed.2010.09.006 ID - Reuter2010 ER -